Effect of sodium glucose cotransporter-2 inhibitors (SGLT-2is) on the clinical outcomes of patients with diabetic atrial fibrillation
Abstract Background Diabetes mellitus (DM) and atrial Fibrillation (AF) are among the most common health issues. They are responsible for the highest rates of morbidity and mortality. The importance of sodium glucose cotransporter-2 inhibitors (SGLT-2is) in treating DM has increased significantly in...
Saved in:
Main Authors: | Selim Aydemir, Sidar Şiyar Aydın, Emrah Aksakal, Onur Altınkaya, Murat Özmen, Oğuzhan Birdal |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-12-01
|
Series: | BMC Cardiovascular Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12872-024-04454-1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sodium glucose co-transporter 2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP-4) inhibitors and the risk of Atrial Fibrillation in patients with type 2 diabetes mellitus: a meta-analysis
by: Xiaoyan Liang, et al.
Published: (2025-01-01) -
Clinical outcomes of atrial fibrillation screening: a meta-analysis of randomized controlled trials
by: Ville Langén, et al.
Published: (2025-12-01) -
A machine learning-based model for predicting paroxysmal and persistent atrial fibrillation based on EHR
by: Yuqi Zhang, et al.
Published: (2025-02-01) -
Elevated plasma trimethyllysine is associated with incident atrial fibrillation
by: Mads M Svenningsson, et al.
Published: (2025-03-01) -
Stroke in Athletes with Atrial Fibrillation: A Narrative Review
by: Joana Certo Pereira, et al.
Published: (2024-12-01)